about
Serum soluble CTLA-4 levels are increased in diffuse cutaneous systemic sclerosisBlockade of CD40/CD40 ligand interactions attenuates skin fibrosis and autoimmunity in the tight-skin mouse.PPARγ downregulation by TGFß in fibroblast and impaired expression and function in systemic sclerosis: a novel mechanism for progressive fibrogenesisCommon and distinct clinical features in adult patients with anti-aminoacyl-tRNA synthetase antibodies: heterogeneity within the syndrome.CD19-dependent B lymphocyte signaling thresholds influence skin fibrosis and autoimmunity in the tight-skin mouseB-lymphocyte depletion reduces skin fibrosis and autoimmunity in the tight-skin mouse model for systemic sclerosisAutoantibodies against phosphatidylserine-prothrombin complex in patients with systemic sclerosis.Intercellular adhesion molecule-1 and L-selectin regulate bleomycin-induced lung fibrosis.Management of squamous cell carcinoma in a patient with recessive-type epidermolysis bullosa dystrophica.Antibody isotype-specific engagement of Fcgamma receptors regulates B lymphocyte depletion during CD20 immunotherapy.The clinical relevance of serum antinuclear antibodies in Japanese patients with systemic sclerosis.CD19 regulates skin and lung fibrosis via Toll-like receptor signaling in a model of bleomycin-induced scleroderma.Cell adhesion molecules regulate fibrotic process via Th1/Th2/Th17 cell balance in a bleomycin-induced scleroderma model.CD19, a response regulator of B lymphocytes, regulates wound healing through hyaluronan-induced TLR4 signaling.Anti-p53 autoantibody in systemic sclerosis: association with limited cutaneous systemic sclerosis.Autoantibody against activating transcription factor-2 in patients with systemic sclerosis.Low zone tolerance requires ICAM-1 expression to limit contact hypersensitivity elicitation.Clinical evaluation of anti-aminoacyl tRNA synthetase antibodies in Japanese patients with dermatomyositis.Autoantibody against one of the antioxidant repair enzymes, methionine sulfoxide reductase A, in systemic sclerosis: association with pulmonary fibrosis and vascular damage.Clinical characteristics of juvenile systemic sclerosis in Japanese.Prevalence and clinical characteristics of anti-Mi-2 antibodies in Japanese patients with dermatomyositis.Idiopathic intracranial hypertension with elevated cerebrospinal fluid level of interleukin-6 in a patient with systemic lupus erythematosus.L-selectin or ICAM-1 deficiency reduces an immediate-type hypersensitivity response by preventing mast cell recruitment in repeated elicitation of contact hypersensitivity.Autoantibody against caspase-3, an executioner of apoptosis, in patients with systemic sclerosis.Increased serum pentraxin 3 in patients with systemic sclerosis.Decreased levels of autoantibody against histone deacetylase 3 in patients with systemic sclerosis.Increased serum levels of N(epsilon)-(hexanoyl)lysine, a new marker of oxidative stress, in systemic sclerosis.Clinical significance of serum hyaluronan levels in systemic sclerosis: association with disease severity.Abnormal natural killer cell function in systemic sclerosis: altered cytokine production and defective killing activity.Correlation of IgE autoantibody to BP180 with a severe form of bullous pemphigoid.Elevated circulating CD40L concentrations in patients with systemic sclerosis.Clinical correlations with dermatomyositis-specific autoantibodies in adult Japanese patients with dermatomyositis: a multicenter cross-sectional study.Autoantibody against a protease domain of caspase-8 in patients with systemic sclerosis.Ultraviolet light exposure suppresses contact hypersensitivity by abrogating endothelial intercellular adhesion molecule-1 up-regulation at the elicitation siteThe cutaneous reverse Arthus reaction requires intercellular adhesion molecule 1 and L-selectin expressionElevated levels of circulating CD44 in patients with systemic sclerosis: association with a milder subsetIncreased serum soluble CD40 levels in patients with systemic sclerosisCD19 regulates the development of bleomycin-induced pulmonary fibrosis in a mouse modelAutoantibody against peroxiredoxin I, an antioxidant enzyme, in patients with systemic sclerosis: possible association with oxidative stressA clue for telangiectasis in systemic sclerosis: elevated serum soluble endoglin levels in patients with the limited cutaneous form of the disease
P50
Q28273141-EF293CCD-3E92-418C-A0C0-AA46DE70DA88Q33297856-BC3C8B28-FE0E-41F9-BE9D-2BE06FB09F61Q33745028-629BDA0A-9A3C-4C10-BA8B-A0877F55FD05Q34661961-1825D0BE-9E88-47A1-83F7-7E5A94C66E42Q34792036-C49EE81C-42A6-46BE-88C8-77ED90344A39Q35222002-71321606-1369-4C7A-B694-CBF0367B6B1CQ35553484-C02D17A0-B959-40E6-8185-608A08C9567CQ35747739-B672B1B7-975C-41D8-93FA-99409D16B282Q35937132-8216B822-7A05-406F-98CF-E71B6A2114F1Q36228329-ACDA9505-8273-414E-840C-3B3A3A19C391Q36592069-20DBE91F-362E-49B2-B740-3B0C8E4C37D4Q36691117-2DAC6B34-0AF2-4ABC-8425-6C1BF8BACB3DQ37069130-2E33D48F-90D1-4C76-87F1-3885D77E47D0Q37278463-2794A3C4-1DA8-4247-A777-B39A1688017EQ38294447-85709F42-5E9A-402E-B2DB-6D94096FC736Q38348832-2517B03A-2B24-4622-AA01-3F6BD0F52371Q38450064-454E7D1E-4300-4A16-81F7-EC9B8912D164Q40457464-2CCC0DD2-861D-4C44-A386-F4AD1AD0592BQ43257884-55773E13-236A-43DB-B396-9DD894B285F7Q43561591-E591FB2D-C6E2-4563-A21D-F79EB6DEB746Q43836174-6B942768-3A2E-452C-801C-5B150F2210FEQ44059630-D0839003-8A8A-4178-BF87-4D29210411EBQ44394565-E9A93572-75B7-420A-BD3E-727B38CFBBF8Q45917138-4BB90B31-28F7-4C85-B9BD-9DFC6ADFA915Q46094329-B55ED28D-ED5B-4684-B0FA-9762E8A5EE76Q46236723-82E76E7E-68D9-4B83-95E3-351D729DDF9EQ46374612-2930C19C-A2FF-4A6F-A5D1-B6D425A97125Q46439214-CC3FC524-3F94-4FB1-8ECE-C375E56536CEQ46721469-A1BF7DDE-5E33-4080-B59B-5DC4F2D6A038Q46798602-2143C3B7-02B7-4E54-A80B-0F8D7EC7FB4AQ48012940-7BDDFB91-F082-452B-9924-E0544E5572C8Q51040689-F183A485-DAB0-4ACA-AD6A-50DADA79055CQ51826837-7BAB6D46-1BDC-4C43-A3D3-3C416CAB026AQ73910665-2ADA0380-4FE4-448F-BD33-57EB1838C3C2Q77743748-769E21C7-8A9A-4E3E-B578-08CAFCEFB1C7Q78328638-5D14559A-B0F1-48B0-AF6C-C8640FCAEB74Q79762553-F485B13B-2156-4391-967B-58915D72B4BFQ79765352-CFB2C632-CAC4-47B0-88A7-1953E1727D2DQ79798517-FB38E752-4AF6-4140-820A-74474F494B1CQ80093841-2C34F665-BFBC-4814-8E94-828C3DE14E5B
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-4775-7356
@en
name
Kazuhiro Komura
@ast
Kazuhiro Komura
@en
Kazuhiro Komura
@es
Kazuhiro Komura
@nl
type
label
Kazuhiro Komura
@ast
Kazuhiro Komura
@en
Kazuhiro Komura
@es
Kazuhiro Komura
@nl
prefLabel
Kazuhiro Komura
@ast
Kazuhiro Komura
@en
Kazuhiro Komura
@es
Kazuhiro Komura
@nl
P106
P1153
7005382499
P31
P496
0000-0002-4775-7356